Maze Therapeutics is a clinical-stage biopharmaceutical company that develops precision medicines rooted in human genetics, specifically targeting kidney and metabolic diseases. With programs like MZE829 and MZE782, the company leverages its unique Compass platform to connect genetic variants to the underlying biological pathways of these diseases, creating novel treatment approaches for patients.
No jobs found. Subscribe below to get notified when we find something for you.
Searching